Literature DB >> 23514293

Still no closure on the question of PFO closure.

Steven R Messé, David M Kent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23514293      PMCID： PMC4420155          DOI： 10.1056/NEJMe1301680

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Minimizing bias in randomized trials: the importance of blinding.

Authors:  Bruce M Psaty; Ross L Prentice
Journal:  JAMA       Date:  2010-08-18       Impact factor: 56.272

2.  Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004.

Authors:  Alexander R Opotowsky; Michael J Landzberg; Stephen E Kimmel; Gary D Webb
Journal:  JAMA       Date:  2008-02-06       Impact factor: 56.272

3.  Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

Authors:  Anthony J Furlan; Mark Reisman; Joseph Massaro; Laura Mauri; Harold Adams; Gregory W Albers; Robert Felberg; Howard Herrmann; Saibal Kar; Michael Landzberg; Albert Raizner; Lawrence Wechsler
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

4.  Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies.

Authors:  J R Overell; I Bone; K R Lees
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

5.  Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community.

Authors:  I Meissner; J P Whisnant; B K Khandheria; P C Spittell; W M O'Fallon; R D Pascoe; M Enriquez-Sarano; J B Seward; J L Covalt; J D Sicks; D O Wiebers
Journal:  Mayo Clin Proc       Date:  1999-09       Impact factor: 7.616

6.  Patent foramen ovale in cryptogenic stroke: incidental or pathogenic?

Authors:  Alawi A Alsheikh-Ali; David E Thaler; David M Kent
Journal:  Stroke       Date:  2009-05-14       Impact factor: 7.914

7.  Off-label closure during CLOSURE study.

Authors:  Kathryn A Stackhouse; Sachin S Goel; Athar M Qureshi; Lourdes Prieto; Samir Kapadia; E Murat Tuzcu; Richard A Krasuski
Journal:  J Invasive Cardiol       Date:  2012-11       Impact factor: 2.022

8.  Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry.

Authors:  Jukka Putaala; Antti J Metso; Tiina M Metso; Nina Konkola; Yvonn Kraemer; Elena Haapaniemi; Markku Kaste; Turgut Tatlisumak
Journal:  Stroke       Date:  2009-02-26       Impact factor: 7.914

9.  Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

Authors:  John D Carroll; Jeffrey L Saver; David E Thaler; Richard W Smalling; Scott Berry; Lee A MacDonald; David S Marks; David L Tirschwell
Journal:  N Engl J Med       Date:  2013-03-21       Impact factor: 91.245

10.  Percutaneous closure of patent foramen ovale in cryptogenic embolism.

Authors:  Bernhard Meier; Bindu Kalesan; Heinrich P Mattle; Ahmed A Khattab; David Hildick-Smith; Dariusz Dudek; Grethe Andersen; Reda Ibrahim; Gerhard Schuler; Antony S Walton; Andreas Wahl; Stephan Windecker; Peter Jüni
Journal:  N Engl J Med       Date:  2013-03-21       Impact factor: 91.245
  10 in total
  11 in total

1.  Controversies in cardioembolic stroke.

Authors:  Benjamin S Wessler; David M Kent
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-01

2.  The RoPE Score and Right-to-Left Shunt Severity by Transcranial Doppler in the CODICIA Study.

Authors:  Benjamin S Wessler; David M Kent; David E Thaler; Robin Ruthazer; Jennifer S Lutz; Joaquín Serena
Journal:  Cerebrovasc Dis       Date:  2015-07-11       Impact factor: 2.762

3.  PFO and ASD Closure in Adulthood: Where Do We Stand?

Authors:  Asad A Rizvi; Ronan Margey
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-04

4.  Cryptogenic stroke-the appropriate diagnostic evaluation.

Authors:  Hardik Amin; David M Greer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

5.  Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke.

Authors:  David M Kent; Jeffrey L Saver; Scott E Kasner; Jason Nelson; John D Carroll; Gilles Chatellier; Geneviève Derumeaux; Anthony J Furlan; Howard C Herrmann; Peter Jüni; Jong S Kim; Benjamin Koethe; Pil Hyung Lee; Benedicte Lefebvre; Heinrich P Mattle; Bernhard Meier; Mark Reisman; Richard W Smalling; Lars Soendergaard; Jae-Kwan Song; Jean-Louis Mas; David E Thaler
Journal:  JAMA       Date:  2021-12-14       Impact factor: 157.335

Review 6.  Management of the stroke patient with patent foramen ovale: new insights and persistent questions in the wake of recent randomized trials.

Authors:  Jessica M Peña; Jorge R Kizer
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

7.  Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials.

Authors:  Georgios D Kitsios; David E Thaler; David M Kent
Journal:  Stroke       Date:  2013-07-18       Impact factor: 7.914

8.  Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials.

Authors:  Yousif Ahmad; James P Howard; Ahran Arnold; Matthew Shun Shin; Christopher Cook; Ricardo Petraco; Ozan Demir; Luke Williams; Juan F Iglesias; Nilesh Sutaria; Iqbal Malik; Justin Davies; Jamil Mayet; Darrel Francis; Sayan Sen
Journal:  Eur Heart J       Date:  2018-05-07       Impact factor: 35.855

Review 9.  Patent Foramen Ovale Closure in 2019.

Authors:  Joel P Giblett; Omar Abdul-Samad; Leonard M Shapiro; Bushra S Rana; Patrick A Calvert
Journal:  Interv Cardiol       Date:  2019-02

10.  Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence.

Authors:  Victoria L Bartlett; Sanket S Dhruva; Nilay D Shah; Patrick Ryan; Joseph S Ross
Journal:  JAMA Netw Open       Date:  2019-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.